Skip to main content
Lirum Therapeutics, Inc. (LRTX)
Lirum Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
5,000,000
Deal Size
$25.00M

Lirum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
 Current20232022
Market Capitalization
45--
Enterprise Value
41--
Debt / Equity Ratio
---0.26
Debt / EBITDA Ratio
--0.26
Debt / FCF Ratio
---1.64
Quick Ratio
1.841.840.10
Interest Coverage
355.84355.84188.59
Return on Equity (ROE)
92.09%92.09%-99.91%
Return on Assets (ROA)
48.16%48.16%468.20%
Return on Capital (ROIC)
-91.83%-91.83%134.35%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).